Ghafouri-Fard S, Khoshbakht T, Hussen BM, Baniahmad A, Branicki W, Taheri M, et al
38.7% (12/31) of patients in the monotherapy group achieved the primary outcome of weight loss 5% from baseline vs
Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex
Oral GLP-1s, such as orforglipron, and monthly injectables, like MariTide, could significantly enhance adherence compared to current weekly injection regimens
Rare Systemic Adverse Effects Even though they are rare, some people might experience systemic side effects
The process is straightforward and most patients report that the injections become routine within the first two to three weeks of treatment